Fundraising for a cure

Donating is simple, fast and totally secure. Your details are safe with us and we will never sell them

309950_122099437888591_3141476_n

Background

Pancreatic Neuroendocrine Tumours (pNET) are increasing in incidence(1), (2).  They carry a relatively poor prognosis compared to other NETs, particularly when hepatic metastasis are present.  We have a proactive management strategy that is agreed in a weekly NET MDT.  We have studied our outcomes and determined survival at 1, 3 & 5 years and compared our outcomes to previously published data.  The data is on our whole cohort not on selected treatments and irrespective of age, fitness, age or co-morbidities.  Click on the link below for full presentation.

Aggressive multi-modality treatment of Pancreatic Neuroendocrine Tumours

How the money raised is spent

See all stories

0